References
- DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980: 303(16): 897–902
- Rentrop P, De Vivie ER, Karsch KR, et al. Acute coronary occlusion with impending infarction as an angiographic complication relieved by a guide wire recanalization. Clin Cardiol 1978: 1(2): 101–6
- Rentrop P, Blanke H, Karsch KR, et al. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981: 63(2): 307–16
- Loscalzo J. An overview of thrombolytic agents. Chest 1990: 97(4 Suppl): 1 17–23S
- Gruppo Italiano per lo Studio della Strep-tochinasi nell'Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987: 2(8564): 871–4
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988: 2(8607): 349–60
- Wilcox RG, von der Lippe G, Olsson CG, et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988: 2(8610): 525–30
- AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report o f the AIMS study. Lancet 1990: 335(8687): 427–31
- The I.S.A.M. Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.): mortality, morbidity, and infarct size at 21 days. N Engl J Med 1986: 314(23): 1465–71
- Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987: 76(1): 142–54
- Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA 1991: 265(13): 1720–3
- Bates ER. Reperfusion therapy in inferior myocardial infarction, J Am Coll Cardiol 1988: 12(6): 44–51A
- Grines CL, DeMaria AN. Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol 1990: 16(1): 223–31
- ACC/AHA Task Force. Guidelines for the early management of patients with acute myocardial infarction. J Am Coll Cardiol 1990: 16(2): 249–92
- The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med 1989: 320(10): 618–27
- Hennekens CH. The Third International Study on Infarct Survival (ISIS-3). In: Clinical perspectives on thrombolysis: symposium workbook. Springfield, NJ: Scientific Therapeutics Information, 1991: 71
- Gang ES, Lew AS, Hong M, et al. Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med 1989: 321 (11): 712–6
- Sager P, Perlmutter R, Rosenfeld L, et al. Thrombolysis decreases sudden death and arrhythmogenic potential after anterior myocardial infarction with aneurysm formation. (Abstr) Circulation 1987: 76(4 Suppl IV): IV261
- Held AC, Gore JM, Paraskos J, et al. Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction. Am J Cardiol 1988: 62(4): 310–1
- Eigler N, Maurer G, Shah PK. Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarction. Am J Cardiol 1984: 54(3): 261–3